secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuo Therapeutics, Inc. (AURX)
CIK:        0001091596
Form:       8-K
Filed at:   2026-06-02T21:41:56+00:00
Accession:  0001437749-26-019199
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuo Therapeutics secures $2M loan facility; issues warrants at $1.50 strike
---------------------------------------------------------------------------

- Amended loan agreement increases aggregate commitment by $400k to $2.0M; $675k funded on May 29, 2026.
- Interest rate raised to 12% on all outstanding notes; interest payable via warrants, not cash.
- Warrants issued at $1.50 exercise price, expiring Jan 23, 2031; includes diverse warrant types.
- Lenders include director Scott Pittman (>10% owner) and Paul Jacobs (>5% owner); proceeds for working capital.
- Mandatory prepayment triggers upon equity financing ≥$5M, change of control, or default.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1091596/000143774926019199/0001437749-26-019199-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1091596/000143774926019199/aurx20260602_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-019199

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer